Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Received authorization from the U.S. FDA and approval from the European Commission for the Company's updated COVID-19 vaccine, and launched the only...
NeoGenomics (NASDAQ:NEO – Get Free Report) updated its FY 2023 earnings guidance on Monday. The company provided earnings per share guidance of -$0.18–$0.15 for the period, compared to the consensus earnings per share estimate of -$0.28. The company issued revenue guidance of $585.00 million-$592.00 million, compared to the consensus revenue estimate of $573.19 million. Analyst […]
Think Research Supporting the Province of Nova Scotia's YourHealthNS ...
Novo Nordisk is spending billions of dollars to boost output and ease shortages of its hugely popular, highly effective weight-loss medicine Wegovy. The Danish drugmaker, which reports...
Novo depends upon a number of companies to help produce Wegovy, but it has released scant details on its supply chain for the weight-loss medicine and its diabetes drug Ozempic containing the same active ingredient. Here are the details of the manufacturing supply chain, based on public statements by Novo and Reuters' reporting: ACTIVE PHARMACEUTICAL INGREDIENT (API) The active pharmaceutical ingredient (API) contained in Wegovy is called semaglutide. Novo says that it produces all of the API for Wegovy at its facilities in Denmark.